07:00 , Jun 23, 2014 |  BioCentury  |  Emerging Company Profile

Amal: Party of two

Amal Therapeutics S.A. is developing a platform of recombinant cancer vaccines that may induce a more potent and durable response than earlier vaccines by activating two different cell types important in antitumor immunity and by...